
Considerations for the Use of Abemaciclib vs Ribociclib in Breast Cancer
Both abemaciclib (Verzenio; Lilly) and ribociclib (Kisqali; Novartis) have adverse effects as well as benefits in cancer treatment, necessitating clear communication between providers and patients when deciding on a treatment regimen, according to …